durapatite has been researched along with losartan potassium in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fagg, B; Roitsch, CA | 1 |
| Hoang, T; Iscove, NN; Odartchenko, N | 1 |
| Agui, T; Hayashida, K; Ikoma, T; Ito, S; Katsuda, S; Nagasaki, K; Nakamura, T; Ohyama, M; Sasaki, N; Sato, H; Tanaka, J; Tonegawa, T | 1 |
| Amanbek, G; Anisimova, N; Bartov, M; Gromov, A; Grunina, T; Kaloshkin, S; Karyagina, A; Kiselevskiy, M; Knyazeva, M; Kolesnikov, E; Krivozubov, M; Lunin, V; Maksimkin, A; Manskikh, V; Nikitin, K; Orlova, P; Poponova, M; Scholz, R; Senatov, F; Strukova, N; Walther, F | 1 |
| Chubrik, A; Generalova, M; Gromov, A; Grunina, T; Karyagina, A; Kolesnikov, E; Krivozubov, M; Lunin, V; Manskikh, V; Nikitin, K; Orlova, P; Permyakova, E; Poponova, M; Ryazanova, A; Senatov, F; Strukova, N; Voronin, A; Zimina, A | 1 |
5 other study(ies) available for durapatite and losartan potassium
| Article | Year |
|---|---|
Characterization of erythropoietin-like activity from mouse spleen cells.
Topics: Animals; Chromatography, High Pressure Liquid; Colony-Stimulating Factors; Durapatite; Electrophoresis, Polyacrylamide Gel; Erythropoietin; Growth Substances; Hematopoietic Cell Growth Factors; Hematopoietic Stem Cells; Hydroxyapatites; Interferon-gamma; Mice; Molecular Weight; Spleen | 1986 |
Macromolecules stimulating human granulocytic colony-forming cells, precursors of these cells, and primitive erythroid progenitors: some apparent nonidentities.
Topics: Chromatography; Colony-Forming Units Assay; Colony-Stimulating Factors; Durapatite; Erythrocytes; Erythropoietin; Granulocytes; Humans; Hydroxyapatites; Isoelectric Focusing; Macromolecular Substances | 1983 |
Amelioration of anemia in the ICGN mouse, a renal anemia model, with a subcutaneous bolus injection of erythropoietin adsorbed to hydroxyapatite matrix.
Topics: Anemia; Animals; Delayed-Action Preparations; Durapatite; Erythropoietin; Glomerulonephritis; Humans; Mice; Mice, Inbred Strains; Recombinant Proteins; Specific Pathogen-Free Organisms; Time Factors | 2009 |
Biomimetic UHMWPE/HA scaffolds with rhBMP-2 and erythropoietin for reconstructive surgery.
Topics: Animals; Biocompatible Materials; Bone and Bones; Bone Diseases; Bone Morphogenetic Protein 2; Bone Regeneration; Drug Carriers; Durapatite; Erythropoietin; Male; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Nanocomposites; Neovascularization, Physiologic; Plastic Surgery Procedures; Polyethylenes; Porosity; Recombinant Proteins; Transforming Growth Factor beta | 2020 |
Effect of recombinant BMP-2 and erythropoietin on osteogenic properties of biomimetic PLA/PCL/HA and PHB/HA scaffolds in critical-size cranial defects model.
Topics: Animals; Biomimetics; Durapatite; Erythropoietin; Mice; Osteogenesis; Polyesters; Porosity; Recombinant Proteins; Tissue Engineering; Tissue Scaffolds | 2022 |